An expert discusses treatment strategies for immune thrombocytopenic purpura (ITP), emphasizing individualized decisions based on platelet count, bleeding symptoms, and comorbidities, with options ...
In a recent study posted to the medRxiv* preprint server, researchers developed a personalized therapy selection algorithm for two diabetes type 2 (T2D) treatment drug classes, i.e., sodium-glucose ...
Mutational Analysis of Circulating Tumor DNA in Patients With Estrogen Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer Receiving Palbociclib: Results From ...
Circulating Tumor DNA Genotyping of Intrinsic and Acquired Gene Alterations in Patients With Advanced Breast Cancer Receiving Palbociclib: Biomarker Results From POLARIS Study FOLFIRINOX (FFX) and ...
The researchers argue that the integration of explainable AI into clinical decision-making pipelines could reshape cancer ...
Gregg is professor of neurobiology and human genetics at the University of Utah. In 2018, I waited until after Christmas to inform my 10- and 12-year-old children that I had metastatic male breast ...
A study published in JAMA Network Open describes the utility of multi-level machine learning models in estimating the risk of delay between cancer diagnosis and treatment initiation in a large group ...
The Pediatric Emergency Medicine and Pediatric Hematology/Oncology divisions at MUSC have joined forces to create and test an algorithm for treating children with sickle cell disease who present to ...
ISSAQUAH, Wash.--(BUSINESS WIRE)--BaroPace Inc. announces its Phase I first-in-human trial of PressurePace TM, its patent-pending pacemaker control algorithm for the treatment of heart failure with ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback